Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures

Protein Science

Volumn 9, Issue 3, 2000, Pages 610-618

  Papageorgiou, Anastassios C ^a   Plano, Lisa R W ^b   Collins, Carleen M ^b   Acharya, K Ravi ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Exfoliative toxin; Serine protease; Staphylococcus aureus; Superantigen; X ray crystallography

Indexed keywords

SERINE PROTEINASE; STAPHYLOCOCCUS TOXIN;

ARTICLE; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS; TOXIC EPIDERMAL NECROLYSIS; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0034022013     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.3.610     Document Type: Article

References (31)

1. Bailey CJ, Redpath MB. 1992. The esterolytic activity of epidermolytic toxins. Biochem J 284:177-180.
2. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, GrosseKunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. 1998. Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D54:905-921.
3. Brünger AT, Kuriyan J, Karplus M. 1987. Crystallographic R-factor refinement by molecular dynamics. Science 235:458-460.
4. Cavarelli J, Prevost G, Bourguet W, Moulinier L, Chevrier B, Delagoutte B, Bilwes A, Mourey L, Rifai S, Piemont Y, Moras D. 1997. The structure of Staphylocuccus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 Å resolution. Structure 5:813-824.
5. (Collaborative Computational Project No. 4), 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D50:760-763.
6. Esnouf RM. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph 15:132-134.
7. Fleisher B, Bailey CJ. 1992. Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med Microbiol Immunol 180:273-278.
8. Ho SN, Hunt HD, Hortin RM, Pullen JK, Pease LR. 1989. Site directed mutagenesis by overlap extension using polymerase chain reaction. Gene 77:51-59.
9. Jackson MP, Iandolo JJ. 1986. Cloning and expression of the exfoliative toxin-B gene from S. aureus. J Bacteriol 166:574-580.
10. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:110-119.
11. Kabsch W, Sander C. 1983. Dictionary of protein secondary structure: Pattern recognition of hydrogen bonded and geometrical features. Biopolymers 22:2577-2637.
12. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, et al. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
13. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. 1999. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 12:224-242.
14. Monday SR, Vath GM, Ferens WA, Deobald C, Rago JV, Gahr PJ, Monie DD, Iandolo JJ, Chapes WC, Ohlendorf DH, et al. 1999. Unique superantigen activity of Staphylococcal exfoliative toxins. J Immunol 162:4450-4559.
15. Navaza J. 1994. AMoRe: An automated package for molecular replacement. Acta Crystallogr A50:157-163.
16. Nienabar VL, Breddam K, Birktoft JJ. 1993. A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding. Biochemistry 32:11469-11475.
17. Novagen. 1997. pET system manual, 7th ed. Madison, Wisconsin: Novagen.
18. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
19. Papageorgiou AC, Acharya KR. 1997. Superantigens as immunomodulators: Recent structural insights. Structure 5:991-996.
20. Perona JJ, Craik CS. 1995. Structural basis of substrate specificity in the serine proteases. Protein Sci 4:337-360.
21. Plano LRW, Gutman DM, Woischnik M, Collins CM. 2000. Recombinant Staphylococcus aureus exfoliative toxins (rETA and rETB) are not bacterial superantigens. Infect Immun. In press.
22. Prévost G, Rifai S, Chaix L, Piémont Y. 1991. Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity. Infect Immun 59:3337-3339.
23. Prévost G, Rifai S, Chaix L, Meyer S, Piémont Y. 1992. Is the His72, Asp120, Ser195 triad constituative of the catalytic site of staphylococcal exfoliation toxin A? In: Witholt B, ed. Bacterial protein toxins, vol. 23. New York: Gustav Fischer, pp 488-489.
24. Read RJ. 1986. Improved Fourier coefficient for maps using phases from partial structures with errors. Acta Crystallogr A42:140-149.
25. Redpath MB, Foster TJ, Bailey CJ. 1991. The role of serine protease active site in the mode of action of epidermolytic toxin of S. aureus. FEMS Microbiol Lett 81:151-156.
26. Sakurai S, Suzuki H, Saito S, Konishi Y, Machida K, Kohno M. 1998. New evidence that the Tyr-157 and Tyr-159 residues of Staphylococcal exfoliative toxin B are essential for its toxicity. Microbiol Immunol 42:829-836.
27. Schechter I, Berger A. 1968. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157-162.
28. Stennicke HR, Birktoft JJ, Breddam K. 1996. Characterization of the S1 binding site of the glutamic-acid specific protease from Streptomyces griseus. Protein Sci 5:2266-2275.
29. Stuart DI, Levine MJ, Muirhead H, Stammers DK. 1979. The crystal structure of cat pyruvate kinase at a resolution of 2.6 Å. J Mol Biol 134:109-142.
30. Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, Ohlendorf DH. 1999. The crystal structure of exfoliative toxin B: A superantigen with enzymatic activity. Biochemistry 38:10239-10246.
31. Vath GM, Earhart CA, Rago JV, Kim MH, Bohach GA, Schlievert PM, Ohlendorf DH. 1997. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 36:1559-1566.